VTAMA® (tapinarof) cream, 1% | Dermavant
WEBLearn more about VTAMA cream, a once-daily, steroid-free topical prescription treatment for adults with mild, moderate or severe plaque psoriasis.
Treat Adult Plaque Psoriasis | VTAMA® (tapinarof) cream, 1%
WEBVTAMA cream is a topical prescription treatment approved by the FDA for adults with plaque psoriasis and is safe for regular, long-term use on all affected external skin areas, as demonstrated in clinical studies over 52 weeks.
FDA Approves Dermavant’s VTAMA
WEBMay 24, 2022 · Dermavant Sciences announced that the U.S. Food and Drug Administration (FDA) has approved VTAMA® cream for the topical treatment of plaque psoriasis in adults.
New Data from Phase 4 Trial of VTAMA® (tapinarof) Cream, 1 ... - Dermavant
WEBOct 16, 2023 · On May 24, 2022, Dermavant announced the FDA approved VTAMA ® (tapinarof) cream, 1% for the treatment of adult plaque psoriasis. The approval made VTAMA cream the first non-steroidal topical novel chemical entity launched for psoriasis in the U.S. in more than 25 years.
Organon to Acquire Dermavant including its Innovative …
WEB3 days ago · The FDA approved VTAMA cream for the topical treatment of mild, moderate, and severe plaque psoriasis in May 2022. Dermavant has been developing VTAMA cream for the treatment of atopic dermatitis in adults and children 2 years of age and older and released positive topline results from its ADORING 1 and 2 …
Treat Adult Plaque Psoriasis | VTAMA® (tapinarof) cream, 1%
WEBLearn more about this steroid-free topical treatment for adults with plaque psoriasis. See study data, patient result and full Prescribing and Safety info.
Dermavant Announces FDA Acceptance of Supplemental New …
WEBOn May 24, 2022, Dermavant announced the FDA approved VTAMA ® (tapinarof) cream, 1% for the treatment of plaque psoriasis in adults. The approval made VTAMA cream the first non-steroidal topical novel chemical entity launched for …
Dermavant Announces Positive Data from the ADORING Phase 3 …
WEBJan 11, 2024 · VTAMA cream is a novel, aryl hydrocarbon receptor agonist in development as a once-daily, cosmetically elegant and steroid-free, topical cream for both acute treatment and long-term...
FDA Approves Dermavant’s VTAMA® (tapinarof) cream, 1% for …
WEBMay 24, 2022 · As the first and only approved drug in its class in the U.S., the FDA’s approval of VTAMA cream provides an effective new non-steroidal treatment option for millions of adults living with plaque...
Phase 3 Data: Dermavant's VTAMA Cream Performs
WEBMar 15, 2023 · Dermavant recently released highly favorable results from a pediatric maximal usage pharmacokinetics (MUPK) study of VTAMA cream in AD. The study demonstrated minimal-to-no systemic exposure despite maximal use.